XTI Aerospace, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that XTI Aerospace, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.49M | Apr 15, 2026 |
| FY2024 | Dec 31, 2024 | $3.20M | Apr 15, 2025 |
| FY2022 | Dec 31, 2022 | $19.42M | Apr 17, 2023 |
| FY2022 | Dec 31, 2021 | $16.00M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $9.30M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $6.30M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $3.76M | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | $3.94M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $53.17M | Mar 27, 2018 |
| FY2016 | Dec 31, 2015 | $66.96M | Apr 17, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $3.20M | Apr 15, 2025 |
| FY2023 | Dec 31, 2023 | $4.56M | Apr 16, 2024 |
| FY2023 | Dec 31, 2022 | $6.11M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $16.00M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $9.30M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $6.30M | Mar 31, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.92M | Apr 15, 2026 |
| FY2024 | Dec 31, 2024 | $1.89M | Apr 15, 2025 |
| FY2023 | Dec 31, 2023 | $3.10M | Apr 16, 2024 |
| FY2023 | Dec 31, 2022 | $3.99M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $11.62M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $6.68M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $4.69M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $2.68M | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | $2.70M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $14.93M | Mar 27, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($68.76M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($35.60M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($25.07M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($63.39M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($69.16M) | Apr 17, 2023 |
| FY2021 | Sep 30, 2021 | ($33.64M) | Mar 16, 2022 |
| FY2021 | Dec 31, 2020 | ($29.23M) | Mar 16, 2022 |
| FY2019 | Dec 31, 2019 | ($17.02M) | Mar 3, 2020 |
| FY2019 | Sep 30, 2019 | ($6.58M) | Mar 3, 2020 |
| FY2019 | Jun 30, 2019 | ($5.23M) | Mar 3, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($42.82M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($29.67M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($7.59M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($19.24M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($72.74M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($23.79M) | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | ($20.81M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($18.40M) | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | ($15.03M) | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | ($23.72M) | Mar 27, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.24M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $1.97M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $1.38M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $4.48M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $14.12M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $6.52M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $3.89M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.23M | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | $964.0K | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $2.28M | Mar 27, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($36.61M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($22.31M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($4.18M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($33.96M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($37.13M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($20.60M) | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | ($10.67M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($26.77M) | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | $2.25M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | ($2.79M) | Mar 27, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $215.0K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $68.0K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $3.0K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $245.0K | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $346.0K | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $972.0K | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $89.0K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $88.0K | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | $101.0K | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $526.0K | Mar 27, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $81.25M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $24.29M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $509.0K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $57.64M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $156.67M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $59.01M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $21.22M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $12.18M | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | $27.69M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $66.47M | Mar 27, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $50.80M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $17.72M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $32.14M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $25.52M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $28.49M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $14.33M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $15.17M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $7.38M | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | $46.54M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $63.76M | Mar 27, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.74M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $6.57M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($31.63M) | Apr 15, 2025 |
| FY2024 | Dec 31, 2022 | ($14.98M) | Apr 15, 2025 |
| FY2022 | Dec 31, 2021 | $81.80M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $44.64M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $6.02M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $4.78M | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | ($16.85M) | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $4.71M | Mar 27, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.54M | Apr 15, 2026 |
| FY2025 | Nov 10, 2025 | $11.50M | Apr 15, 2026 |
| FY2024 | Dec 31, 2024 | $12.07M | Apr 15, 2025 |
| FY2025 | Mar 31, 2024 | $12.40M | Apr 15, 2026 |
| FY2022 | Dec 31, 2022 | $0 | Apr 17, 2023 |
| FY2022 | Dec 31, 2021 | $7.67M | Apr 17, 2023 |
| FY2022 | Dec 31, 2020 | $6.59M | Apr 17, 2023 |
| FY2021 | Dec 31, 2019 | $2.07M | Mar 16, 2022 |
| FY2020 | Dec 31, 2018 | $0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $636.0K | Mar 3, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($162.32M) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($93.56M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | ($57.96M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($313.74M) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | ($250.31M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($180.99M) | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | ($151.76M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($117.77M) | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | ($94.49M) | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | ($59.47M) | Mar 27, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.70M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $3.97M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $5.0K | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $9.28M | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | $52.48M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $18.00M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | $4.78M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.01M | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | $119.0K | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $1.82M | Mar 27, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $450.0K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $65.0K | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $18.55M | Apr 15, 2025 |
| FY2019 | Dec 31, 2018 | $74.0K | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | $767.0K | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $4.05M | Mar 27, 2018 |
| FY2016 | Dec 31, 2015 | $1.23M | Apr 17, 2017 |
| FY2015 | Dec 31, 2014 | $100.0K | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $292.0K | Mar 27, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (4) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | (162) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | (1,576) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | (3,412) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | (51) | Apr 17, 2023 |
| FY2021 | Sep 30, 2021 | 0 | Mar 16, 2022 |
| FY2021 | Dec 31, 2020 | (1) | Mar 16, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (4) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | (162) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | (1,576) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | (3,412) | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | (51) | Apr 17, 2023 |
| FY2021 | Sep 30, 2021 | 0 | Mar 16, 2022 |
| FY2021 | Dec 31, 2020 | (1) | Mar 16, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 32.79M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 1.69M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 12,791 | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | 35,709 | Apr 16, 2024 |
| FY2022 | Dec 31, 2021 | 1.73M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 53.18M | Mar 16, 2022 |
| FY2020 | Dec 31, 2019 | 4.23M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 35,158 | Mar 3, 2020 |
| FY2018 | Dec 31, 2017 | 24,042 | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | 71,866 | Mar 27, 2018 |